About Jonathan Montagu

Previous experience in startup Operations, Business Development, pharmaceutical Marketing and New Product Development in biotech and big pharma setting. Former management consultant with training as synthetic organic chemist. 12 years based in Cambridge, MA and San Francisco, CA. Now based in Boston and Berlin, Germany.

HOTSPOT THERAPEUTICS
• President & Chief Executive Officer

EPIIOS THERAPEUTICS
• Chief Executive Officer & Managing Director

NIMBUS THERAPEUTICS
* Responsible for Business Development, Finance, Legal, Operations, IT reporting to Chairman of Board
* Completed $42MM Series A financing led by Atlas Venture, SR One, Lilly Ventures, Gates Ventures
* Transactions with Shire, Schrödinger, Monsanto, Genentech.

ATLAS VENTURE – Executive-in-Residence

CONCERT PHARMACEUTICALS
* Responsible for out-licensing efforts around lead programs (anti-infectives, diabetes, anti-fibrotic) and non-traditional BD including animal health, foundations, federal funding and API manufacturing
* Driving New Product Development activities including target product profile development, forecasting, portfolio prioritization, business case development across multiple programs and disease indications

ORTHO-McNEIL PHARMACEUTICALS
* New Product Development Manager for US launch of doripenem and ceftobiprole, two anti-infective products

STANFORD GRADUATE SCHOOL OF BUSINESS

BIOGEN IDEC: Associate, Business Development

CHIRON CORPORATION: Special Advisor
* Program Leader, BioPharma Research Strategy
* Project Co-Lead, Chiron Manufacturing Initiative (CMI)

BOSTON CONSULTING GROUP: Consultant
* Post-merger integration for multinational pharma company
* IP-licensing strategy for a $10B research funding organization

Research experience
* The Scripps Research Institute
* Cold Spring Harbor Laboratory
* Imperial Cancer Research Fund
* Oxford University Dyson Perrins Laboratory